[Fatal adverse effects. Experience of the Midi-Pyrénées Pharmacovigilance Center]

Adverse Effects of Treatment with Valproic Acid during the Neonatal Period.

Neuropediatrics·2018

Peripheral arterial occlusive disease during ponatinib therapy after failure of imatinib: a case report.

Journal of clinical pharmacy and therapeutics·2016

Cardiovascular risk profile of patients with peripheral arterial occlusive disease during nilotinib therapy.

Targeted oncology·2016

Medication exposure and spontaneous abortion: a case-control study using a French medical database.

Clinical and experimental obstetrics & gynecology·2015

Severe adverse effects of bromocriptine in lactation inhibition: a pharmacovigilance survey.

BJOG : an international journal of obstetrics and gynaecology·2015

Use of administrative hospital database to identify adverse drug reactions in a Pediatric University Hospital.

European journal of clinical pharmacology·2014

Distinct pattern of reported adverse event with SGLT2 inhibitors in heart failure: A pharmacovigilance study using VigiBase data.

Therapie·2026

[Buprenorphine and pain management: Clinical insights and practical landmarks].

Therapie·2026

[Five years of ISO 9001 certification in pharmacotoxicology: Experience feedback and implementation modalities in vigilance structures].

Therapie·2026

Epidemiology and risk factors of severe cutaneous drug reactions and evaluation through available databases.

Therapie·2026

Characteristics of patients with opioid/benzodiazepine use disorder in a specialized consultation unit for prescription drug addiction: A cross-sectional study.

Therapie·2026

Anhedonia and neuropsychotropics: A pharmacovigilance-pharmacodynamic study.

Therapie·2026

Fluoropyrimidine-associated gastrointestinal toxicity: pharmacovigilance reporting signals and in vitro evidence of epithelial injury, barrier impairment, and inflammatory responses.

Frontiers in immunology·2026

A Difference-in-Differences Analysis of Low-Value Opioid Utilization for Acute Low Back Pain, 2019-2021.

PRiMER (Leawood, Kan.)·2026

Impact of opioid agonist therapies on non-fatal and fatal overdose: treatment patterns among individuals with opioid use disorder in Ontario, Canada.

Frontiers in public health·2026

Efficacy and safety of P2X3 receptor antagonists in refractory or unexplained chronic cough: an updated systematic review and meta-analysis.

Frontiers in pharmacology·2026

Approaches in Opioid Pharmacology: Toward Safer Pain Management.

FASEB journal : official publication of the Federation of American Societies for Experimental Biology·2026

The 2026 British Society for Rheumatology guideline for the treatment of polymyalgia rheumatica.

Rheumatology (Oxford, England)·2026

Related Experiment Videos

[Fatal adverse effects. Experience of the Midi-Pyrénées Pharmacovigilance Center]

Related Concept Videos

Adverse Effects of Treatment with Valproic Acid during the Neonatal Period.

Peripheral arterial occlusive disease during ponatinib therapy after failure of imatinib: a case report.

Cardiovascular risk profile of patients with peripheral arterial occlusive disease during nilotinib therapy.

Medication exposure and spontaneous abortion: a case-control study using a French medical database.

Severe adverse effects of bromocriptine in lactation inhibition: a pharmacovigilance survey.

Use of administrative hospital database to identify adverse drug reactions in a Pediatric University Hospital.

Distinct pattern of reported adverse event with SGLT2 inhibitors in heart failure: A pharmacovigilance study using VigiBase data.

[Buprenorphine and pain management: Clinical insights and practical landmarks].

[Five years of ISO 9001 certification in pharmacotoxicology: Experience feedback and implementation modalities in vigilance structures].

Epidemiology and risk factors of severe cutaneous drug reactions and evaluation through available databases.

Characteristics of patients with opioid/benzodiazepine use disorder in a specialized consultation unit for prescription drug addiction: A cross-sectional study.

Anhedonia and neuropsychotropics: A pharmacovigilance-pharmacodynamic study.

Fluoropyrimidine-associated gastrointestinal toxicity: pharmacovigilance reporting signals and in vitro evidence of epithelial injury, barrier impairment, and inflammatory responses.

A Difference-in-Differences Analysis of Low-Value Opioid Utilization for Acute Low Back Pain, 2019-2021.

Impact of opioid agonist therapies on non-fatal and fatal overdose: treatment patterns among individuals with opioid use disorder in Ontario, Canada.

Efficacy and safety of P2X3 receptor antagonists in refractory or unexplained chronic cough: an updated systematic review and meta-analysis.

Approaches in Opioid Pharmacology: Toward Safer Pain Management.

The 2026 British Society for Rheumatology guideline for the treatment of polymyalgia rheumatica.

Related Experiment Videos

[Fatal adverse effects. Experience of the Midi-Pyrénées Pharmacovigilance Center]

Related Concept Videos

Related Articles